XML 48 R24.htm IDEA: XBRL DOCUMENT
v3.20.2

Intangible Assets and Goodwill (Tables) | 6 Months Ended
--- | ---
Jun. 28, 2020
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets and Goodwill |
(Dollars in Millions) |  | June 28, 2020 |  | December 29, 2019
Intangible assets with definite lives: |  |  |  |
Patents and trademarks — gross |  | $ | 37,313 |  |  | 36,634 |
Less accumulated amortization |  | 14,834 |  |  | 13,154 |
Patents and trademarks — net |  | 22,479 |  |  | 23,480 |
Customer relationships and other intangibles — gross |  | 22,272 |  |  | 22,056 |
Less accumulated amortization |  | 10,072 |  |  | 9,462 |
Customer relationships and other intangibles — net* |  | 12,200 |  |  | 12,594 |
Intangible assets with indefinite lives: |  |  |  |
Trademarks |  | 6,927 |  |  | 6,922 |
Purchased in-process research and development (1) |  | 5,807 |  |  | 4,647 |
Total intangible assets with indefinite lives |  | 12,734 |  |  | 11,569 |
Total intangible assets — net |  | $ | 47,413 |  |  | 47,643 |
*The majority is comprised of customer relationships (1) In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc., and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.
Goodwill | Goodwill as of June 28, 2020 was allocated by segment of business as follows:
(Dollars in Millions) |  | Consumer Health |  | Pharmaceutical |  | Medical Devices |  | Total
Goodwill at December 29, 2019 |  | $ | 9,736 |  |  | 9,169 |  |  | 14,734 |  |  | 33,639 |
Goodwill, related to acquisitions |  | — |  |  | 1 |  |  | 183 |  |  | 184 |
Currency translation/Other |  | 10 |  |  | 45 |  |  | 12 |  |  | 67 |
Goodwill at June 28, 2020 |  | $ | 9,746 |  |  | 9,215 |  |  | 14,929 |  |  | 33,890 |
Intangible Asset Amortization Expense | The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:
(Dollars in Millions) |  |  |  |  |  |  |  |
2020 |  | 2021 |  | 2022 |  | 2023 |  | 2024
$4,500 |  | 4,300 |  | 4,100 |  | 4,100 |  | 4,000

X
- Definition Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block] + References No definition available. + Details
Name: | jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock
Namespace Prefix: | jnj_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration